中国医学创新  2024, Vol. 21 Issue (26): 32-35    DOI: 10.3969/j.issn.1674-4985.2024.26.008
Clinical research Current Issue | Archive | Adv Search |
Effect and Safety of Pertuzumab in the Treatment of Patients with HER2-positive Breast Cancer
DONG Zhengyu
First-author's address: Department of Oncology, Yancheng Second People's Hospital, Yancheng 224003, China
Download: PDF (1075 KB)   HTML (1 KB) 
Export: BibTeX | EndNote (RIS)      
Received: 26 January 2024     
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
DONG Zhengyu
Cite this article:   
DONG Zhengyu. Effect and Safety of Pertuzumab in the Treatment of Patients with HER2-positive Breast Cancer[J]. 中国医学创新, 2024, 21(26): 32-35.
URL:  
http://www.zgyxcx.com/EN/10.3969/j.issn.1674-4985.2024.26.008     OR     http://www.zgyxcx.com/EN/Y2024/V21/I26/32
© 2016 中国医学创新 editorial
Address: Beijing south cellular road number five      Postcodes: 100055